Elutia (ELUT) Debt Ratio (2019 - 2025)

Elutia (ELUT) posted Debt Ratio of 0.89 for Q3 2025, up 19.61% sequentially from 0.74 in Q2 2025, and up 89.78% YoY from 0.47 in Q3 2024.

Elutia (ELUT) Debt Ratio (2019 - 2025) Analysis & Trends

Elutia has reported Debt Ratio for 7 years, with the latest figure at 0.89 in Q3 2025.

Quarterly Debt Ratio rose 89.78% year-over-year to 0.89 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was 0.89 (up 89.78% YoY) and the FY2024 annual result came in at 0.66, up 21.1% from the prior year.
Debt Ratio climbed to 0.89 in Q3 2025 per ELUT's latest filing, from 0.74 in the prior quarter.
Over five years, Debt Ratio peaked at 0.89 in Q3 2025 and troughed at 0.23 in Q4 2021.
A 5-year average of 0.46 and a median of 0.46 in 2023 frame the typical range for Debt Ratio.
The sharpest annual moves came in 2021 and 2025: Debt Ratio sank 42.6% in 2021, then soared 89.78% in 2025.
Over 5 years, Debt Ratio stood at 0.23 in 2021, then soared by 56.01% to 0.35 in 2022, then soared by 54.71% to 0.55 in 2023, then increased by 21.1% to 0.66 in 2024, then soared by 34.44% to 0.89 in 2025.
According to Business Quant data, Debt Ratio over the past three periods registered 0.89, 0.74, and 0.62 for Q3 2025, Q2 2025, and Q1 2025 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Debt Ratio (Qtr)
1	Abbott Laboratories	198.70 Bn	193.10 Bn	7.27 Bn	0.30
2	Stryker	125.85 Bn	122.37 Bn	4.50 Bn	0.31
3	Medtronic	118.44 Bn	109.22 Bn	6.41 Bn	0.30
4	Boston Scientific	72.64 Bn	72.10 Bn	3.85 Bn	0.28
5	Edwards Lifesciences	51.94 Bn	47.69 Bn	1.35 Bn	0.04
6	Dexcom	34.48 Bn	32.53 Bn	830.00 Mn	-
7	GE HealthCare Technologies	33.60 Bn	31.49 Bn	2.18 Bn	0.27
8	Koninklijke Philips	26.30 Bn	22.98 Bn	4.55 Bn	0.28
9	Steris	23.00 Bn	22.52 Bn	684.20 Mn	0.18
10	Elutia	39.87 Mn	19.98 Mn	1.45 Mn	-

Download Data